Description |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Pharmasol |
|
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Manufacture Deva Holding / Marketed by Searle |
Letrozole 2.5mg |
Product Type |
Product Size |
Injection
|
1'S |
Product Company |
Helix pharma
|
Doxorubicin 50mg/25ml
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Roche Pharma |
Bevacizumab 400mg/16ml |
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Martin Dow |
Anastrozole 1mg |
Product Type |
Product Size |
Tablet |
60'S |
Product Company |
Pharma Solution |
Sorafenib 500mg |
Content | Vincristine is a chemotherapy drug that belongs to a group of drugs called vinca alkaloids. Vincristine works by stopping the cancer cells from separating into 2 new cells. So, it stops the growth of the cancer. | Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon. | Doxorubicin is a type of chemotherapy drug called an anthracycline. It slows or stops the growth of cancer cells by blocking an enzyme called topo isomerase 2. Cancer cells need this enzyme to divide and grow.
| "
Bevacizumab is a type of targeted cancer drug treatment. It is also known as Avastin. It is a treatment for a number of different cancer types. | Anastrozole is a type of hormone treatment. It works by lowering the levels of oestrogen hormones in your body. It is mainly prescribed for women who have been through the menopause and have a type of cancer called hormone-dependent breast cancer. | Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer that has come back or spread to other parts of your body.
|
Reviews
There are no reviews yet.